Nalkem Pharmaceuticals India Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Nalkem Pharmaceuticals India Private Limited

Nalkem Pharmaceuticals India Private Limited, a active private limited company, was established on 25 November 2019 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33208TG2019PTC137114. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.00 M.

Formerly known as Sridev Pharma Private Limited. It upholds a compliant status. Its leadership includes Rajee Dakshayani Nalla (Director), Venkata Laxmi Lakkimsetty (Additional Director), Keerthi Priyanka Katta (Director). Past directors included Revanth Balla, Vijaya Lakshmi Kasina. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 83/B2, 1St Floor, Phase-1 Road No.18, Ida, Jeedimetla, Hyderabad, Telangana, 500055.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33208TG2019PTC137114

  • Registration Number

    137114

  • Incorporation Date

    25 November 2019

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹5.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 5.00 M
  • Company Age 6 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -97.75%
  • Profit Growth **** 100.37%
  • Ebitda **** 101.82%
  • Net Worth 0.20%
  • Total Assets -10.60%
Company report

Nalkem Pharmaceuticals India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nalkem Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nalkem Pharmaceuticals India Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajee Dakshayani Nalla Director 16 Oct 2020 Current
Venkata Laxmi Lakkimsetty Additional Director 17 Jun 2024 Current
Keerthi Priyanka Katta Director 25 Nov 2019 Current
Jaya Bhanu Venkata Nageswara Rao Nalla Additional Director 17 Jun 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Sep 2022 Past
Pramod Abcsdd Director 12 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nalkem Pharmaceuticals India.

Nalkem Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 97.75% decrease. The company also saw a substantial improvement in profitability, with a 100.37% increase in profit. The company's net worth moved up by a moderate rise of 0.2%.

Nalkem Pharmaceuticals India revenue growth over time
Nalkem Pharmaceuticals India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -97.75%
*******
*******
*******
*******
Revenue from Operations
*******
 -98.28%
*******
*******
*******
*******
Total Assets
*******
 -10.60%
*******
*******
*******
*******
Profit or Loss
*******
 100.37%
*******
*******
*******
*******
Net Worth
*******
 0.20%
*******
*******
*******
*******
EBITDA
*******
 101.82%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nalkem Pharmaceuticals India?

Unlock access to Nalkem Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nalkem Pharmaceuticals India?

Unlock and access historical data on people associated with Nalkem Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nalkem Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nalkem Pharmaceuticals India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nalkem Pharmaceuticals India
Recent Activity within the Organization
  • Annual General Meeting

    The activity Nalkem Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Director Appointment

    The activity Venkata Laxmi Lakkimsetty was appointed as a Additional Director was appointed as a Additional Director on 17 Jun 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Director Appointment

    The activity Jaya Bhanu Venkata Nageswara Rao Nalla was appointed as a Additional Director was appointed as a Additional Director on 17 Jun 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Balance Sheet

    Progress on Nalkem Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Director Appointment

    The activity Rajee Dakshayani Nalla was appointed as a Director was appointed as a Director on 16 Oct 2020 & has been associated with this company since 5 years 5 months . was completed.

  • Director Appointment

    The activity Keerthi Priyanka Katta was appointed as a Director was appointed as a Director on 25 Nov 2019 & has been associated with this company since 6 years 3 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nalkem Pharmaceuticals India Private Limited?

The CIN of Nalkem Pharmaceuticals India Private Limited is U33208TG2019PTC137114.

Where is Nalkem Pharmaceuticals India Private Limited headquartered?

Nalkem Pharmaceuticals India Private Limited is headquartered at Plot No 83/B2, 1St Floor, Phase-1 Road No.18, Ida, Jeedimetla, Hyderabad, Telangana, 500055.

When was Nalkem Pharmaceuticals India Private Limited incorporated?

Nalkem Pharmaceuticals India Private Limited was incorporated on 25 November 2019.

Who are the current directors of Nalkem Pharmaceuticals India Private Limited?

The current directors of Nalkem Pharmaceuticals India Private Limited are

What is the primary industry of Nalkem Pharmaceuticals India Private Limited?

The primary industry of Nalkem Pharmaceuticals India Private Limited is Trade.

Is Nalkem Pharmaceuticals India Private Limited a listed company?

Nalkem Pharmaceuticals India Private Limited is unlisted.

What is the capital structure of Nalkem Pharmaceuticals India Private Limited?

The authorized capital of Nalkem Pharmaceuticals India Private Limited is ₹1.00 Cr, and the paid-up capital is ₹5.00 M.

What is the compliance status of Nalkem Pharmaceuticals India Private Limited?

The compliance status of Nalkem Pharmaceuticals India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available